LEVELS OF CXCL10/IP-10 FORMS AND SOLUBLE CD26/DPPIV ACTIVITY AS EARLY PREDICTIVE BIOMARKERS FOR HIV/SIV ASSOCIATED MUCOSAL INFLAMMATION AND PROGRESSION TOWARDS AIDS

摘要

The invention provides methods for the identification of patients capable of controlling HIV progression, as well as to the identification of an antagonist form of IP-10 associated to HIV progression control and the uses thereof for improving the immunological response of HIV patients.